Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo

Antiviral Therapy

Volumn 1, Issue 3, 1996, Pages 141-146

  Offensperger, Wolf Bernhard ^a   Offensperger, Silke ^a   Keppler Hafkemeyer, Andrea ^a   Hafkemeyer, Peter ^a   Blum, Hubert E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOPURINE; ACICLOVIR; ANTIVIRUS AGENT; DRUG DERIVATIVE; FAMCICLOVIR; PENCICLOVIR;

ANIMAL; ARTICLE; DRUG EFFECT; DUCK; HEPATITIS B VIRUS; LIVER CELL; VIROLOGY; VIRUS INFECTION; VIRUS REPLICATION;

2-AMINOPURINE; ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; DUCKS; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B VIRUS, DUCK; HEPATOCYTES; VIRUS REPLICATION;

EID: 0030201563     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mason WS, Seal G & Summers J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. Journal of Virology 1980; 36:829-836.
2. Wang GH & Seeger C. Novel mechanism for reverse transcription in hepatitis B viruses. Journal of Virology 1993; 67:6507-6512.
3. Berk L, Schalm SW & Heijtink RA. Zidovudine inhibits hepatitis B virus replication. Antiviral Research 1992; 19:111-118.
4. Farraye FA, Mamish DM & Zeldis JB. Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in AIDS patients. Journal of Medical Virology 1989; 29:266-267.
5. Hoofnagle JH, Minuk GY, Dusheiko GM, Schafer DF, Johnson R, Straus S, Jones EA, Gerin JL & Ishak K. Adenine arabinoside 5′-monophosphate treatment of chronic type B hepatitis. Hepatology 1982; 2:784-788.
6. Alexander GJM, Fagan EA & Hegarty JE. Controlled clinical trial of acyclovir in chronic hepatitis B virus infection. Journal of Medical Virology 1987; 21:81-87.
7. Schalm SW, Heijtink RA, Van Buuren HR & De Man RA. Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B. Lancet 1985; i:358-360.
8. Locarnini SA, Guo K, Lucas CR & Gust ID. Inhibition of HBV DNA replication by ganciclovir in patients with AIDS. Lancet 1989; ii:1225-1226.
9. Kakumu S, Yoshioka K, Ishikawa T, Takyanagi M & Higashi Y. Pilot study of ribavirin and interferon-β for chronic hepatitis B. Hepatology 1993; 18:258-263.
10. McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie A, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Pruett T, Stotka JL, Straus SE & Hoofnagle JH. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. New England Journal of Medicine 1995; 333:1099-1105.
11. Fried MW, Korenman H & Hoofnagle JH. A pilot study of 2′,3′-dideoxyinosine (DDI) in chronic hepatitis B. Gastroenterology 1991; 100:741A.
12. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C & Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. New England Journal of Medicine 1995; 333:1657-1661
13. Sprengel R & Will H. Duck hepatitis B virus. In Virus Diseases in Laboratory and Captive Animals. Edited by H Darai. 1988; pp 363-386. Boston: Martinus Nijhoff Publishers.
14. Hirota K, Sherker AH, Omata M, Yokosuka O & Okuda K. Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection. Hepatology 1987; 7:24-28.
15. Kassianides C, Hoofnagle JH, Miller RH, Doo E, Ford H, Broder S & Mitsuya H. Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxycytidine. Gastroenterology 1989; 97:1275-1280.
16. Lee B, Luo W, Suzuki S, Robins MJ & Tyrrell DLJ. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2′,3′-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrobial Agents and Chemotherapy 1989; 33:336-339.
17. Suzuki S, Lee B, Lou W, Tovell D, Robins MJ & Tyrrell DLJ. Inhibition of duck hepatitis B virus replication by purine 2′,3′dideoxynucleosides. Biochemical and Biophysical Research Communications 1988; 156:1144-1151.
18. Yokota T, Konno K, Chonan E, Mochizuki S, Kojima K, Shigeta S & de Clercq E. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro. Antimicrobial Agents and Chemotherapy 1990; 34:1326-1330.
19. Fourel I, Gripon P, Hantz O, Cova L, Lambert V, Jacquet C, Watanabe K, Fox J, Guillouzo C & Trepo C. Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: a useful system for antiviral testing. Hepatology 1989; 10:186-191.
20. Fourel I, Li J, Hantz O, Jacquet C, Fox J & Trepo C. Effects of 2′-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks. Journal of Medical Virology 1992; 37:122-126.
21. Haritani H, Uchida T, Okuda Y & Shikata T. Effect of 3′azido-3′-deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro. Journal of Medical Virology 1989; 29:244-248.
22. Heijtink RA, De Wilde GA, Kruining J, Berk L, Baizarini J, de Clercq E, Holy A & Schalm SW. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection. Antiviral Research 1993; 21:141-153.
23. Wang YY, Bowden S, Shaw T, Civitico G, Chan Y, Qiao M & Locarnini S. Inhibition of duck hepatitis B virus replication in vivo by the nucleoside analogue ganciclovir (9-(2-hydroxy-hydroxy-methyl)ethoxymethyl)guanine). Antiviral Chemistry & Chemotherapy 1991; 2:107-114.
24. Wang YY, Luscombe C, Bowden S, Shaw T & Locarnini S. Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid. Antimicrobial Agents and Chemotherapy 1995; 34:1326-1330.
25. Niu J, Wang YY, Dixon R, Bowden S, Qiao M, Einck L & Locarnini S. The use of ampligen alone and in combination with ganciclovir and coumermycin Al for the treatment of ducks congenitally infected with duck hepatitis B virus. Antiviral Research 1993; 21:155-171.
26. Hung LF, Brumbaugh AE, Bhatia G, Marion PL, Hung PP, Norbeck DW, Plattner JJ & Robinson WS. Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell culture. Journal of Medical Virology 1991; 35:180-186.
27. Fourel I, Saputelli J, Schaffer P & Mason WS. The carbocyclic analog of 2′-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver. Journal of Virology 1994; 68:1059-1065.